Files

Download poster

Download Full Text (798 KB)

Description

Primary Objective

  • Characterize the pharmacokinetics of vancomycin in plasma, dialysate, and urine following a single intraperitoneal dose

Secondary Objective

  • Explore the safety, tolerability, and feasibility in administering vancomycin during the long dwell period in patients on APD

Publication Date

9-13-2019

Keywords

vancomycin, automated peritoneal dialysis, peritonitis, pharmacokinetics

Disciplines

Medicine and Health Sciences | Pharmacy and Pharmaceutical Sciences

Comments

Presented at the 2019 American College of Clinical Pharmacology (AACP) Annual Meeting

Pharmacokinetics of intraperitoneal vancomycin in patients on automated peritoneal dialysis

Share

COinS